Saba Capital Management, L.P. bought HQL
May 23, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 1,303 shares of Abrdn Life Sciences Investors at $13.50 per share, a transaction worth $17.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,303
Price
$13.50
Total value
$17.6K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 23, 2024
Filing dateMay 23, 2024
Shares owned after3,251,883
OwnershipIndirect
10b5-1 planNo
AmendedNo